AAAAAA
Results:
1-8
|
Results: 8
Authors:
Mannhold, R
van de Waterbeemd, H
Citation: R. Mannhold et H. Van De Waterbeemd, Substructure and whole molecule approaches for calculating log P, J COMPUT A, 15(4), 2001, pp. 337-354
Authors:
van de Waterbeemd, H
Smith, DA
Jones, BC
Citation: H. Van De Waterbeemd et al., Lipophilicity in PK design: methyl, ethyl, futile, J COMPUT A, 15(3), 2001, pp. 273-286
Authors:
van de Waterbeemd, H
Smith, DA
Beaumont, K
Walker, DK
Citation: H. Van De Waterbeemd et al., Property-based design: Optimization of drug absorption and pharmacokinetics, J MED CHEM, 44(9), 2001, pp. 1313-1333
Authors:
van de Waterbeemd, H
Citation: H. Van De Waterbeemd, Role of human CYP3A and P-glycoprotein on the absorption of drugs, EUR J PH SC, 12(1), 2000, pp. 1-1
Authors:
van de Waterbeemd, H
Citation: H. Van De Waterbeemd, Intestinal permeability: Prediction from theory, DRUG PHARM, 106, 2000, pp. 31-49
Authors:
Smith, DA
van de Waterbeemd, H
Citation: Da. Smith et H. Van De Waterbeemd, Pharmacokinetics and metabolism in early drug discovery, CURR OP C B, 3(4), 1999, pp. 373-378
Authors:
van de Waterbeemd, H
Camenisch, G
Folkers, G
Chretien, JR
Raevsky, OA
Citation: H. Van De Waterbeemd et al., Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors, J DRUG TAR, 6(2), 1998, pp. 151-165
Authors:
van de Waterbeemd, H
Citation: H. Van De Waterbeemd, The fundamental variables of the biopharmaceutics classification system (BCS): a commentary, EUR J PH SC, 7(1), 1998, pp. 1-3
Risultati:
1-8
|